Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome

PURPOSE: Features of polycystic ovarian syndrome (PCOS) including sonographic aspects, androgens, LH and LH/FSH ratio as well as Anti-Mullerian Hormone (AMH) were evaluated according to their diagnostic potency in detecting different degrees of PCOS severity. - METHODS: 80 women with PCOS diagnosed...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Köninger, Angela (VerfasserIn) , Koch, L. (VerfasserIn) , Edimiris, P. (VerfasserIn) , Enekwe, A. (VerfasserIn) , Nagarajah, J. (VerfasserIn) , Kasimir-Bauer, S. (VerfasserIn) , Kimmig, R. (VerfasserIn) , Strowitzki, Thomas (VerfasserIn) , Schmidt, B. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 25 June 2014
In: Archives of gynecology and obstetrics
Year: 2014, Jahrgang: 290, Heft: 5, Pages: 1023-1030
ISSN:1432-0711
DOI:10.1007/s00404-014-3317-2
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00404-014-3317-2
Volltext
Verfasserangaben:Angela Köninger, L. Koch, P. Edimiris, A. Enekwe, J. Nagarajah, S. Kasimir-Bauer, R. Kimmig, T. Strowitzki, B. Schmidt

MARC

LEADER 00000caa a2200000 c 4500
001 1747643831
003 DE-627
005 20220819100200.0
007 cr uuu---uuuuu
008 210205s2014 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00404-014-3317-2  |2 doi 
035 |a (DE-627)1747643831 
035 |a (DE-599)KXP1747643831 
035 |a (OCoLC)1341391731 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Köninger, Angela  |d 1976-  |e VerfasserIn  |0 (DE-588)123908736  |0 (DE-627)085517534  |0 (DE-576)293937710  |4 aut 
245 1 0 |a Anti-Mullerian Hormone  |b an indicator for the severity of polycystic ovarian syndrome  |c Angela Köninger, L. Koch, P. Edimiris, A. Enekwe, J. Nagarajah, S. Kasimir-Bauer, R. Kimmig, T. Strowitzki, B. Schmidt 
264 1 |c 25 June 2014 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.02.2021 
520 |a PURPOSE: Features of polycystic ovarian syndrome (PCOS) including sonographic aspects, androgens, LH and LH/FSH ratio as well as Anti-Mullerian Hormone (AMH) were evaluated according to their diagnostic potency in detecting different degrees of PCOS severity. - METHODS: 80 women with PCOS diagnosed according to the Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2003 and 48 controls were enrolled between 2011 and 2013. PCOS patients fulfilling all Rotterdam criteria were defined as having severe PCOS (n = 59), while patients showing oligo-/amenorrhoea and polycystic ovaries but without hyperandrogenemia were defined as having mild PCOS (n = 21). All patients were treated at the University Hospital of Essen, Germany. - RESULTS: The strongest group difference between controls and severe PCOS patients was observed for AMH showing an age-adjusted odds ratio of 2.56 [95 % confidence interval (CI) 2.00-3.27; p < 0.0001]. Age-adjusted receiver operating characteristic analysis showed that the area under the curve (AUC) of 0.88 (95 % CI: 0.80-0.95) for AMH and 0.94 (95 % CI 0.88-0.98) for antral follicle count did not differ significantly in their ability to discriminate between severe PCOS patients and controls. AMH showed higher AUC estimates than androgens, ovarian volume, LH and LH/FSH ratio and an AUC of 0.80 (95 % CI: 0.65-0.91) for detecting mild PCOS. - CONCLUSIONS: To our knowledge, this is the first study comparing the diagnostic potency of AMH, sonographic aspects, androgens, and LH/FSH ratio according to different PCOS subgroups while accounting for the age-dependency of AMH. In cases where vaginal scans are not feasible or in patients without hyperandrogenemia AMH may be used as a surrogate parameter in PCOS diagnosis, superior to androgens and gonadotropins. 
650 4 |a Adolescent 
650 4 |a Adult 
650 4 |a Androgens 
650 4 |a Anti-Mullerian Hormone 
650 4 |a Biomarkers 
650 4 |a Case-Control Studies 
650 4 |a Female 
650 4 |a Follicle Stimulating Hormone 
650 4 |a Germany 
650 4 |a Gonadotropins 
650 4 |a Hospitals, University 
650 4 |a Humans 
650 4 |a Hyperandrogenism 
650 4 |a Luteinizing Hormone 
650 4 |a Middle Aged 
650 4 |a Ovarian Follicle 
650 4 |a Polycystic Ovary Syndrome 
650 4 |a Predictive Value of Tests 
650 4 |a ROC Curve 
650 4 |a Sensitivity and Specificity 
650 4 |a Severity of Illness Index 
650 4 |a Ultrasonography 
650 4 |a Young Adult 
700 1 |a Koch, L.  |e VerfasserIn  |4 aut 
700 1 |a Edimiris, P.  |e VerfasserIn  |4 aut 
700 1 |a Enekwe, A.  |e VerfasserIn  |4 aut 
700 1 |a Nagarajah, J.  |e VerfasserIn  |4 aut 
700 1 |a Kasimir-Bauer, S.  |e VerfasserIn  |4 aut 
700 1 |a Kimmig, R.  |e VerfasserIn  |4 aut 
700 1 |a Strowitzki, Thomas  |d 1959-  |e VerfasserIn  |0 (DE-588)118055917  |0 (DE-627)079216099  |0 (DE-576)17102141X  |4 aut 
700 1 |a Schmidt, B.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Archives of gynecology and obstetrics  |d Berlin : Springer, 1987  |g 290(2014), 5, Seite 1023-1030  |h Online-Ressource  |w (DE-627)253390060  |w (DE-600)1458450-5  |w (DE-576)072283270  |x 1432-0711  |7 nnas  |a Anti-Mullerian Hormone an indicator for the severity of polycystic ovarian syndrome 
773 1 8 |g volume:290  |g year:2014  |g number:5  |g pages:1023-1030  |g extent:8  |a Anti-Mullerian Hormone an indicator for the severity of polycystic ovarian syndrome 
856 4 0 |u https://doi.org/10.1007/s00404-014-3317-2  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210205 
993 |a Article 
994 |a 2014 
998 |g 118055917  |a Strowitzki, Thomas  |m 118055917:Strowitzki, Thomas  |d 910000  |d 910400  |e 910000PS118055917  |e 910400PS118055917  |k 0/910000/  |k 1/910000/910400/  |p 8 
999 |a KXP-PPN1747643831  |e 3849420132 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Köninger, Angela","family":"Köninger","role":"aut","given":"Angela"},{"given":"L.","role":"aut","display":"Koch, L.","family":"Koch"},{"family":"Edimiris","display":"Edimiris, P.","given":"P.","role":"aut"},{"family":"Enekwe","display":"Enekwe, A.","given":"A.","role":"aut"},{"given":"J.","role":"aut","family":"Nagarajah","display":"Nagarajah, J."},{"display":"Kasimir-Bauer, S.","family":"Kasimir-Bauer","given":"S.","role":"aut"},{"role":"aut","given":"R.","display":"Kimmig, R.","family":"Kimmig"},{"given":"Thomas","role":"aut","display":"Strowitzki, Thomas","family":"Strowitzki"},{"display":"Schmidt, B.","family":"Schmidt","role":"aut","given":"B."}],"title":[{"subtitle":"an indicator for the severity of polycystic ovarian syndrome","title_sort":"Anti-Mullerian Hormone","title":"Anti-Mullerian Hormone"}],"note":["Gesehen am 05.02.2021"],"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"25 June 2014"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Angela Köninger, L. Koch, P. Edimiris, A. Enekwe, J. Nagarajah, S. Kasimir-Bauer, R. Kimmig, T. Strowitzki, B. Schmidt"]},"recId":"1747643831","id":{"doi":["10.1007/s00404-014-3317-2"],"eki":["1747643831"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["GG, Deutsche Gesellschaft für Gynäkologie und Geburtshilfe"]},"recId":"253390060","pubHistory":["Volume 241, issue 1 (March 1987)-"],"id":{"issn":["1432-0711"],"eki":["253390060"],"zdb":["1458450-5"]},"disp":"Anti-Mullerian Hormone an indicator for the severity of polycystic ovarian syndromeArchives of gynecology and obstetrics","part":{"issue":"5","year":"2014","pages":"1023-1030","text":"290(2014), 5, Seite 1023-1030","extent":"8","volume":"290"},"origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedDisp":"1987-","publisher":"Springer","dateIssuedKey":"1987"}],"note":["Gesehen am 10.07.25","Fortsetzung der Druck-Ausgabe"],"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Gynecology and obstetrics"}],"title":[{"title":"Archives of gynecology and obstetrics","title_sort":"Archives of gynecology and obstetrics"}],"language":["eng"]}]} 
SRT |a KOENINGERAANTIMULLER2520